相关实验视频

Updated: Oct 9, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.2K

在患有复发性和/或耐火性急性淋巴细胞白血病的患者中进行sapanisertib的第二阶段和药理学研究

Aref Al-Kali1, Ibrahim Aldoss2, Pamela J Atherton1

  • 1Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.

Cancer medicine
|November 14, 2023
PubMed
概括

作为口服TORC1/2抑制剂的Sapanisertib在复发性急性淋巴细胞白血病 (ALL) 患者中表现出良好的安全性,但仅作为单一药物,其有效性和制目标是有限的.

关键词:
所有的,所有的,所有的.急性淋巴细胞白血病急性淋巴细胞白血病这是一种mTOR抑制剂.萨帕尼塞尔蒂布 (Sapanisertib) 是一个

更多相关视频

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-308:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

1.1K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:39

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

122

相关概念视频

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...